Irwin Naturals Inc.

IWIN

CA46414Q1054

Pharmaceuticals

End-of-day quote Canadian Securities Exchange Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
0.12 ^USD	-14.29%		-14.29%	-36.84%

Mar. 29	Irwin Naturals, Inc. Announces CFO Changes	CI
Mar. 29	Irwin Naturals, Inc. Announces Directors Changes	CI

Irwin Naturals, Inc. Announces Directors Changes

March 29, 2024 at 06:57 am EDT

Irwin Naturals, Inc. announced that Rod Kight and Sheri Orlowitz have tendered their resignations as directors of the Company effective February 14, 2024 . The Company thanks Mr. Kight and Ms. Orlowitz for their contributions to the Company and wishes them the best of luck in their future endeavors. Klee Irwin will remain as chairman of the Board of Directors.

Moreover, the Company announced the new board members that have been elected to fill the aforementioned vacancies, Luke Lokhorst and Lyle Maxson. Their terms on the board began February 14, 2024. Lyle Maxson is at the forefront healthcare innovation including founding and serving as a board member on companies leveraging Artificial Intelligence and plant medicine to push healthcare system forward.

Luke Lokhorst holds a Masters Degree in International Business and Sustainable Finance and are excited to add him to the leadership team.

Latest news about Irwin Naturals Inc.

Irwin Naturals, Inc. Announces CFO Changes	Mar. 29	CI
Irwin Naturals, Inc. Announces Directors Changes	Mar. 29	CI
Tranche Update on Irwin Naturals, Inc.'s Equity Buyback Plan announced on September 26, 2022.	Nov. 22	CI
Irwin Naturals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 22	CI
Transcript : Irwin Naturals, Inc. - Shareholder/Analyst Call	23-09-28
Irwin Naturals, Inc.'s Equity Buyback announced on September 26, 2022, has closed with 81,000 shares, representing 3.74% for CAD 0.21 million.	23-09-25	CI
Irwin Naturals Swings to Loss in Q2, Revenue Grows	23-08-28	MT
Irwin Naturals Announces Goodwill Impairment for the Second Quarter Ended June 30, 2023	23-08-25	CI
Tranche Update on Irwin Naturals, Inc.'s Equity Buyback Plan announced on September 26, 2022.	23-08-25	CI
Irwin Naturals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-25	CI
Irwin Naturals Inc. Announces Licensing and Supply Agreement with The Hive Laboratory, LLC	23-07-28	CI
Irwin Naturals, Inc. Appoints Sheri Orlowitz as New Director	23-06-01	CI
Irwin Naturals, Inc. Reports Impairment Charges for the First Quarter Ended March 31, 2023	23-05-31	CI
Tranche Update on Irwin Naturals, Inc.'s Equity Buyback Plan announced on September 26, 2022.	23-05-29	CI
Irwin Naturals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-29	CI
Tranche Update on Irwin Naturals, Inc.'s Equity Buyback Plan announced on September 26, 2022.	23-05-25	CI
Irwin Naturals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-05-25	CI
Irwin Naturals, Inc. Auditor Raises 'Going Concern' Doubt	23-05-24	CI
Irwin Naturals Inc. Announces Directorate Changes	23-05-02	CI
Irwin Naturals Inc. terminated agreement to acquire Assets of Tri-Cities Infusion & Wellness Clinic, PLLC.	23-05-01	CI
Irwin Naturals Launches New Product in Canada	23-03-24	MT
Irwin Naturals Brief: Says Cannabis Products Launch Nationwide in Canada	23-03-24	MT
Irwin Naturals Inc. Announces the Release of Irwin Naturals Cannabis' New CBD 25mg Softgels in Canada	23-03-24	CI
Irwin Naturals Closes Purchase of Ketamine Media	23-03-22	MT
Irwin Naturals Inc. completed the acquisition of Keta Media, LLC.	23-03-16	CI

Chart Irwin Naturals Inc.

Duration

Period

More charts

Company Profile

Irwin Naturals Inc. (Irwin) is a nutraceutical company. The Company is engaged in distributing cannabidiol (CBD) products in mass-market and health food chain stores across the United States. Irwin's portfolio of herbal products is available in more than 100,000 retail doors across North America. The Company's full range of Vitamin, CBD, and Supplements features over 100 products, created to address mood and brain function, better sleep, sports performance, sexual health, immune support, weight management, women's health and men's health. The Company's ketamine clinic, Emergence, is an infusion clinic that offers intravenous (IV) ketamine for the treatment of depression, post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), anxiety, bipolar disorder, migraines, and multiple chronic pain conditions such as complex regional pain syndrome (CRPS), reflex sympathetic dystrophy (RSD) and fibromyalgia.

Sector

Pharmaceuticals

Calendar

2024-04-28 - Q4 2023 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
IRWIN NATURALS INC.	-36.84%	295K
MCKESSON CORPORATION	+17.35%	71.39B
SINOPHARM GROUP CO. LTD.	+5.38%	8.59B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+6.69%	8.19B
HUADONG MEDICINE CO., LTD	-20.96%	7.91B
H. LUNDBECK A/S	+0.49%	4.54B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+17.12%	4.31B
EBOS GROUP LIMITED	-3.38%	3.93B
GALENICA AG	-2.61%	3.86B
CHINA NATIONAL MEDICINES CORPORATION LTD.	+22.08%	3.64B

Pharmaceuticals Wholesale